Guardant Health
GH
#1124
Rank
HK$164.26 B
Marketcap
HK$1,214
Share price
-0.37%
Change (1 day)
59.52%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of November 2026 (TTM): 17.8

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -94.4. At the end of 2023 the company had a P/S ratio of 5.82.

P/S ratio history for Guardant Health from 2018 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Neogen
NEOG
2.87-83.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
17.1-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA